341 related articles for article (PubMed ID: 25318968)
1. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A
Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968
[TBL] [Abstract][Full Text] [Related]
2. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
3. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
Hanly JG; Robichaud J; Fisk JD
J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
[TBL] [Abstract][Full Text] [Related]
4. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.
Harrison MJ; Ravdin LD; Lockshin MD
Arthritis Rheum; 2006 Aug; 54(8):2515-22. PubMed ID: 16868972
[TBL] [Abstract][Full Text] [Related]
5. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
Lapteva L; Nowak M; Yarboro CH; Takada K; Roebuck-Spencer T; Weickert T; Bleiberg J; Rosenstein D; Pao M; Patronas N; Steele S; Manzano M; van der Veen JW; Lipsky PE; Marenco S; Wesley R; Volpe B; Diamond B; Illei GG
Arthritis Rheum; 2006 Aug; 54(8):2505-14. PubMed ID: 16868971
[TBL] [Abstract][Full Text] [Related]
6. Systemic lupus erythematosus impairs memory cognitive tests not affected by depression.
Calderón J; Flores P; Babul M; Aguirre JM; Slachevsky A; Padilla O; Scoriels L; Henríquez C; Cárcamo C; Bravo-Zehnder M; González A; Massardo L
Lupus; 2014 Sep; 23(10):1042-53. PubMed ID: 24879658
[TBL] [Abstract][Full Text] [Related]
7. Pathogenicity of lupus anti-ribosomal P antibodies: role of cross-reacting neuronal surface P antigen in glutamatergic transmission and plasticity in a mouse model.
Segovia-Miranda F; Serrano F; Dyrda A; Ampuero E; Retamal C; Bravo-Zehnder M; Parodi J; Zamorano P; Valenzuela D; Massardo L; van Zundert B; Inestrosa NC; González A
Arthritis Rheumatol; 2015 Jun; 67(6):1598-610. PubMed ID: 25709106
[TBL] [Abstract][Full Text] [Related]
8. Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.
Chang EH; Volpe BT; Mackay M; Aranow C; Watson P; Kowal C; Storbeck J; Mattis P; Berlin R; Chen H; Mader S; Huerta TS; Huerta PT; Diamond B
EBioMedicine; 2015 Jul; 2(7):755-64. PubMed ID: 26286205
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.
Conti F; Alessandri C; Perricone C; Scrivo R; Rezai S; Ceccarelli F; Spinelli FR; Ortona E; Marianetti M; Mina C; Valesini G
PLoS One; 2012; 7(3):e33824. PubMed ID: 22461897
[TBL] [Abstract][Full Text] [Related]
10. [Central neuropsychiatric involvement in systemic lupus erythematosus].
Madrane S; Ribi C
Rev Med Suisse; 2012 Apr; 8(337):848-53. PubMed ID: 22594009
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, involved domains, and predictor of cognitive dysfunction in systemic lupus erythematosus.
Yue R; Gurung I; Long XX; Xian JY; Peng XB
Lupus; 2020 Nov; 29(13):1743-1751. PubMed ID: 32938321
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment and autoantibodies in systemic lupus erythematosus.
Hanly JG; Walsh NM; Fisk JD; Eastwood B; Hong C; Sherwood G; Jones JV; Jones E; Elkon K
Br J Rheumatol; 1993 Apr; 32(4):291-6. PubMed ID: 8461922
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus.
Szmyrka M; Pokryszko-Dragan A; Słotwiński K; Gruszka E; Korman L; Podemski R; Wiland P
Adv Clin Exp Med; 2019 Feb; 28(2):185-192. PubMed ID: 29963787
[TBL] [Abstract][Full Text] [Related]
14. Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study.
Park DJ; Takahashi Y; Kang JH; Yim YR; Kim JE; Lee JW; Lee KE; Lee JK; Lee SS
Clin Exp Rheumatol; 2017; 35 Suppl 105(3):54-60. PubMed ID: 28339361
[TBL] [Abstract][Full Text] [Related]
15. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.
Kowal C; Degiorgio LA; Lee JY; Edgar MA; Huerta PT; Volpe BT; Diamond B
Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19854-9. PubMed ID: 17170137
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
17. Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies.
Schwarting A; Möckel T; Lütgendorf F; Triantafyllias K; Grella S; Boedecker S; Weinmann A; Meineck M; Sommer C; Schermuly I; Fellgiebel A; Luessi F; Weinmann-Menke J
Ann Rheum Dis; 2019 Sep; 78(9):1226-1234. PubMed ID: 31186256
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors.
Omdal R; Brokstad K; Waterloo K; Koldingsnes W; Jonsson R; Mellgren SI
Eur J Neurol; 2005 May; 12(5):392-8. PubMed ID: 15804272
[TBL] [Abstract][Full Text] [Related]
19. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Takayama M; Yoshio T
Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
[TBL] [Abstract][Full Text] [Related]
20. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
McLaurin EY; Holliday SL; Williams P; Brey RL
Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
